info@arvd-symposium.org    

01. Historical Perspective
02. Genetic Background of ARVD
03. Clinical Manifestation
04. Task Force Criteria
05. Ventricular tachyarrhythmias
06. Role of EP testing
07. Differential diagnosis with RVOT
08. ECG findings
09. Echo findings
10. RV Angio
11. Biopsy findings
12. Autopsy findings
13. MRI
14. CARTO Mapping
15. Risk Stratification
16. Naxos Disease
17. How to manage family members
18. ARVD vs. other cardiomyopathies – common pathway
19. Genotype-Phenotype Associations
20. Therapy in ARVD
21. ICD in ARVD
22. European Registry
23. North American Registry
24. Signal averaged ECG
25. Viral hypothesis
26. ARVD as paradigm for studying cardiomyopathies
27. Relation of ARVD with the Brugada syndrome
28. Sports Activities and ARVD
29. Japanese experience with ARVD
30. Progression of ARVD
31. Overall talk on ARVD preceding Symposium
32. Etiology of ARVD
33. Diagnosing ARVD
34. Management of ARVD Patients